Greg Jennings, LLC’s AbbVie ABBV Stock Holding History

Greg Jennings, LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.31M	Buy	+27,954	New	+$7.17M	5.14%	8

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Greg Jennings, LLC's ABBV Position: Q3 2026 in Review

Greg Jennings, LLC opened a new position in AbbVie (ABBV) in Q3 2026: 27,954 shares worth $7.31M. The stake represents 5.14% of the portfolio and ranks #8 among its holdings.

1,143 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Greg Jennings, LLC held 27,954 shares of AbbVie worth $7.31M as of Q3 2026.
AbbVie was a new Greg Jennings, LLC position in Q3 2026.
AbbVie made up 5.14% of Greg Jennings, LLC's portfolio in Q3 2026, its #8 holding.
1,143 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Greg Jennings, LLC's 13F filing for Q3 2026, filed 19 Oct 2026.